P85α mediates p53 k370 acetylation by p300 and regulates its promoter-specific transactivity in the cellular uvb response

P85α mediates p53 k370 acetylation by p300 and regulates its promoter-specific transactivity in the cellular uvb response

Play all audios:

Loading...

ABSTRACT Inducible acetylation of p53 at lysine residues has a great impact on regulating the transactivation of this protein, which is associated with cell growth arrest and/or apoptosis


under various stress conditions. However, the factor(s) for regulating p53 acetylation remains largely unknown. In the current study, we have shown that p85α, the regulatory subunit of


phosphatidylinositol-3-kinase, has a critical role in mediating p53 acetylation and promoter-specific transactivation in the ultraviolet B (UVB) response. Depletion of p85α in mouse


embryonic fibroblasts significantly impairs UVB-induced apoptosis, as well as p53 transactivation and acetylation at Lys370 (Lys373 of human p53); however, the accumulation, nuclear


translocation and phosphorylation of p53 are not affected. Interestingly, p85α binds to p300, promotes the p300–p53 interaction and the subsequent recruitment of the p53/p300 complex to the


promoter region of the specific p53 target gene in response to UVB irradiation. Moreover, ablation of p53 acetylation at Lys370 by site-directed mutagenesis dramatically suppresses


UVB-induced expression of the specific p53-responsive gene as well as cell apoptosis. Therefore, we conclude that p85α is a novel regulator of p53-mediated response under certain stress


conditions, and targeting the p85α-dependent p53 pathway may be promising for cancer therapy. Access through your institution Buy or subscribe This is a preview of subscription content,


access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 50 print issues and online access $259.00 per year only $5.18 per issue Learn


more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS


OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS VPRBP/DCAF1 REGULATES P53 FUNCTION AND STABILITY


THROUGH SITE-SPECIFIC PHOSPHORYLATION Article Open access 11 April 2023 DECIPHERING THE ACETYLATION CODE OF P53 IN TRANSCRIPTION REGULATION AND TUMOR SUPPRESSION Article 29 April 2022 A


P53–PHOSPHOINOSITIDE SIGNALOSOME REGULATES NUCLEAR AKT ACTIVATION Article 07 July 2022 REFERENCES * An W, Kim J, Roeder RG . (2004). Ordered cooperative functions of PRMT1, p300, and CARM1


in transcriptional activation by p53. _Cell_ 117: 735–748. Article  CAS  PubMed  Google Scholar  * Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K . (1997). Recruitment


of p300/CBP in p53-dependent signal pathways. _Cell_ 89: 1175–1184. Article  CAS  PubMed  Google Scholar  * Brooks CL, Gu W . (2003). Ubiquitination, phosphorylation and acetylation: the


molecular basis for p53 regulation. _Curr Opin Cell Biol_ 15: 164–171. Article  CAS  PubMed  Google Scholar  * Brooks CL, Gu W . (2008). p53 activation: a case against Sir. _Cancer Cell_ 13:


377–378. Article  CAS  PubMed  PubMed Central  Google Scholar  * Cao C, Lu S, Kivlin R, Wallin B, Card E, Bagdasarian A _et al_. (2008). SIRT1 confers protection against UVB- and


H(2)O(2)-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes. _J Cell Mol Med_ 4: 4. Google Scholar  * Chao C, Wu Z, Mazur SJ, Borges H, Rossi M, Lin T _et al_.


(2006). Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage. _Mol Cell Biol_ 26: 6859–6869. Article  CAS  PubMed  PubMed Central  Google


Scholar  * Eischen CM, Lozano G . (2009). p53 and MDM2: antagonists or partners in crime? _Cancer Cell_ 15: 161–162. Article  CAS  PubMed  Google Scholar  * Feng L, Lin T, Uranishi H, Gu W,


Xu Y . (2005). Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity. _Mol Cell Biol_ 25: 5389–5395. Article  CAS


  PubMed  PubMed Central  Google Scholar  * Geering B, Cutillas PR, Vanhaesebroeck B . (2007). Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits? _Biochem Soc Trans_


35: 199–203. Article  CAS  PubMed  Google Scholar  * Goodman RH, Smolik S . (2000). CBP/p300 in cell growth, transformation, and development. _Genes Dev_ 14: 1553–1577. CAS  PubMed  Google


Scholar  * Grossman SR . (2001). p300/CBP/p53 interaction and regulation of the p53 response. _Eur J Biochem_ 268: 2773–2778. Article  CAS  PubMed  Google Scholar  * Gu W, Roeder RG .


(1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. _Cell_ 90: 595–606. Article  CAS  PubMed  Google Scholar  * Haupt Y, Maya R, Kazaz A,


Oren M . (1997). Mdm2 promotes the rapid degradation of p53. _Nature_ 387: 296–299. Article  CAS  PubMed  Google Scholar  * Iyer NG, Ozdag H, Caldas C . (2004). p300/CBP and cancer.


_Oncogene_ 23: 4225–4231. Article  CAS  PubMed  Google Scholar  * Juan L-J, Shia W-J, Chen M-H, Yang W-M, Seto E, Lin Y-S _et al_. (2000). Histone deacetylases specifically down-regulate


p53-dependent gene activation. _J Biol Chem_ 275: 20436–20443. Article  CAS  PubMed  Google Scholar  * Kim EJ, Kho JH, Kang MR, Um SJ . (2007). Active regulator of SIRT1 cooperates with


SIRT1 and facilitates suppression of p53 activity. _Mol Cell_ 28: 277–290. Article  CAS  PubMed  Google Scholar  * Kitagawa M, Lee SH, McCormick F . (2008). Skp2 suppresses p53-dependent


apoptosis by inhibiting p300. _Mol Cell_ 29: 217–231. Article  CAS  PubMed  Google Scholar  * Kruse JP, Gu W . (2009). Modes of p53 regulation. _Cell_ 137: 609–622. Article  CAS  PubMed 


PubMed Central  Google Scholar  * Kubbutat MHG, Jones SN, Vousden KH . (1997). Regulation of p53 stability by Mdm2. _Nature_ 387: 299–303. Article  CAS  PubMed  Google Scholar  * Kurash JK,


Lei H, Shen Q, Marston WL, Granda BW, Fan H _et al_. (2008). Methylation of p53 by Set7/9 mediates p53 acetylation and activity _in vivo_. _Mol Cell_ 29: 392–400. Article  CAS  PubMed 


Google Scholar  * Lain S, Hollick JJ, Campbell J, Staples OD, Higgins M, Aoubala M _et al_. (2008). Discovery, _in vivo_ activity, and mechanism of action of a small-molecule p53 activator.


_Cancer Cell_ 13: 454–463. Article  CAS  PubMed  PubMed Central  Google Scholar  * Latonen L, Laiho M . (2005). Cellular UV damage responses—functions of tumor suppressor p53. _Biochim


Biophys Acta_ 1755: 71–89. CAS  PubMed  Google Scholar  * Levine AJ, Hu W, Feng Z . (2006). The P53 pathway: what questions remain to be explored? _Cell Death Differ_ 13: 1027–1036. Article


  CAS  PubMed  Google Scholar  * Li M, Luo J, Brooks CL, Gu W . (2002). Acetylation of p53 inhibits its ubiquitination by Mdm2. _J Biol Chem_ 277: 50607–50611. Article  CAS  PubMed  Google


Scholar  * Lill NL, Grossman SR, Ginsberg D, DeCaprio J, Livingston DM . (1997). Binding and modulation of p53 by p300/CBP coactivators. _Nature_ 387: 823–827. Article  CAS  PubMed  Google


Scholar  * Liu G, Chen X . (2006). Regulation of the p53 transcriptional activity. _J Cell Biochem_ 97: 448–458. Article  CAS  PubMed  Google Scholar  * Liu L, Scolnick DM, Trievel RC, Zhang


HB, Marmorstein R, Halazonetis TD _et al_. (1999). p53 sites acetylated _in vitro_ by PCAF and p300 are acetylated _in vivo_ in response to DNA damage. _Mol Cell Biol_ 19: 1202–1209.


Article  CAS  PubMed  PubMed Central  Google Scholar  * Luo J, Field SJ, Lee JY, Engelman JA, Cantley LC . (2005). The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates


IRS-1 signaling via the formation of a sequestration complex. _J Cell Biol_ 170: 455–464. Article  CAS  PubMed  PubMed Central  Google Scholar  * Luo J, Li M, Tang Y, Laszkowska M, Roeder


RG, Gu W . (2004). Acetylation of p53 augments its site-specific DNA binding both _in vitro_ and _in vivo_. _Prog Natl Acad Sci USA_ 101: 2259–2264. Article  CAS  Google Scholar  * Luo J,


Nikolaev AY, Imai S, Chen D, Su F, Shiloh A _et al_. (2001). Negative control of p53 by Sir2alpha promotes cell survival under stress. _Cell_ 107: 137–148. Article  CAS  PubMed  Google


Scholar  * Luo J, Su F, Chen D, Shiloh A, Gu W . (2000). Deacetylation of p53 modulates its effect on cell growth and apoptosis. _Nature_ 408: 377–381. Article  CAS  PubMed  Google Scholar 


* Manning BD, Cantley LC . (2007). AKT/PKB signaling: navigating downstream. _Cell_ 129: 1261–1274. Article  CAS  PubMed  PubMed Central  Google Scholar  * Miled N, Yan Y, Hon WC, Perisic O,


Zvelebil M, Inbar Y _et al_. (2007). Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. _Science_ 317: 239–242. Article  CAS  PubMed  Google


Scholar  * Olsson A, Manzl C, Strasser A, Villunger A . (2007). How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?


_Cell Death Differ_ 14: 1561–1575. Article  CAS  PubMed  Google Scholar  * Pan X, Zhao J, Zhang WN, Li HY, Mu R, Zhou T _et al_. (2009). Induction of SOX4 by DNA damage is critical for p53


stabilization and function. _Proc Natl Acad Sci USA_ 106: 3788–3793. Article  CAS  PubMed  PubMed Central  Google Scholar  * Pedeux R, Sengupta S, Shen JC, Demidov ON, Saito S, Onogi H _et


al_. (2005). ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation. _Mol Cell Biol_ 25: 6639–6648. Article  CAS  PubMed  PubMed Central  Google


Scholar  * Reczek EE, Flores ER, Tsay AS, Attardi LD, Jacks T . (2003). Multiple response elements and differential p53 binding control Perp expression during apoptosis. _Mol Cancer Res_ 1:


1048–1057. CAS  PubMed  Google Scholar  * Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A _et al_. (1998). DNA damage activates p53 through a phosphorylation-acetylation


cascade. _Genes Dev_ 12: 2831–2841. Article  CAS  PubMed  PubMed Central  Google Scholar  * Sasaki T, Gan EC, Wakeham A, Kornbluth S, Mak TW, Okada H . (2007). HLA-B-associated transcript 3


(Bat3)/Scythe is essential for p300-mediated acetylation of p53. _Genes Dev_ 21: 848–861. Article  CAS  PubMed  PubMed Central  Google Scholar  * Song L, Li J, Hu M, Huang C . (2008). Both


IKKalpha and IKKbeta are implicated in the arsenite-induced AP-1 transactivation correlating with cell apoptosis through NF-kappaB activity-independent manner. _Exp Cell Res_ 314: 2187–2198.


Article  CAS  PubMed  PubMed Central  Google Scholar  * Song L, Li J, Ye J, Yu G, Ding J, Zhang D _et al_. (2007). p85alpha acts as a novel signal transducer for mediation of cellular


apoptotic response to UV radiation. _Mol Cell Biol_ 27: 2713–2731. Article  CAS  PubMed  PubMed Central  Google Scholar  * Song L, Li J, Zhang D, Liu ZG, Ye J, Zhan Q _et al_. (2006).


IKKbeta programs to turn on the GADD45alpha-MKK4-JNK apoptotic cascade specifically via p50 NF-kappaB in arsenite response. _J Cell Biol_ 175: 607–617. Article  CAS  PubMed  PubMed Central 


Google Scholar  * Sykes SM, Mellert HS, Holbert MA, Li K, Marmorstein R, Lane WS _et al_. (2006). Acetylation of the p53 DNA-binding domain regulates apoptosis induction. _Mol Cell_ 24:


841–851. Article  CAS  PubMed  PubMed Central  Google Scholar  * Tang Y, Luo J, Zhang W, Gu W . (2006). Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest


and apoptosis. _Mol Cell_ 24: 827–839. Article  CAS  PubMed  Google Scholar  * Tang Y, Zhao W, Chen Y, Zhao Y, Gu W . (2008). Acetylation is indispensable for p53 activation. _Cell_ 133:


612–626. Article  CAS  PubMed  PubMed Central  Google Scholar  * Ueki K, Fruman DA, Brachmann SM, Tseng YH, Cantley LC, Kahn CR . (2002a). Molecular balance between the regulatory and


catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. _Mol Cell Biol_ 22: 965–977. Article  CAS  PubMed  PubMed Central  Google Scholar  * Ueki K, Yballe CM,


Brachmann SM, Vicent D, Watt JM, Kahn CR _et al_. (2002b). Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase. _Proc Natl Acad Sci USA_ 99: 419–424.


Article  CAS  PubMed  Google Scholar  * Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK _et al_. (2001). hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. _Cell_


107: 149–159. Article  CAS  PubMed  Google Scholar  * Wang J, Ouyang W, Li J, Wei L, Ma Q, Zhang Z _et al_. (2005). Loss of tumor suppressor p53 decreases PTEN expression and enhances


signaling pathways leading to activation of activator protein 1 and nuclear factor {kappa}B induced by UV radiation. _Cancer Res_ 65: 6601–6611. Article  CAS  PubMed  Google Scholar  * Yin


Y, Terauchi Y, Solomon GG, Aizawa S, Rangarajan PN, Yazaki Y _et al_. (1998). Involvement of p85 in p53-dependent apoptotic response to oxidative stress. _Nature_ 391: 707–710. Article  CAS


  PubMed  Google Scholar  * Zhao W, Kruse JP, Tang Y, Jung SY, Qin J, Gu W . (2008). Negative regulation of the deacetylase SIRT1 by DBC1. _Nature_ 451: 587–590. Article  CAS  PubMed  PubMed


Central  Google Scholar  * Zhu Z, Luo Z, Li Y, Ni C, Li H, Zhu M . (2009). Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent


manner. _Hepatology_ 49: 504–512. Article  CAS  PubMed  Google Scholar  Download references ACKNOWLEDGEMENTS We appreciate the technical help from Dr Dan Liu and the helpful discussion


provided by Dr Ailing Li. This project is partially supported by NIH/NCI CA112557, CA119028-05S110, NIH/NIEHS ES010344 and ES012451 (to Dr C Huang); and National Natural Science Foundation


of China No. 30871277, 30970594, Beijing Natural Science Foundation 5092022 and 5102035 and the National Key Research and Development Programs on Fundamental Sciences (973 Project)


2011CB503803 (to Dr L Song). AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Environmental Medicine, Nelson Institute of Environmental Medicine, New York University School of


Medicine, Tuxedo, NY, USA L Song, J Li, X Shi & C Huang * Department of Cellular Immunology, Beijing Institute of Basic Medical Sciences, Beijing, People's Republic of China L Song,


 M Gao, W Dong, M Hu, Y Hao & Y Li Authors * L Song View author publications You can also search for this author inPubMed Google Scholar * M Gao View author publications You can also


search for this author inPubMed Google Scholar * W Dong View author publications You can also search for this author inPubMed Google Scholar * M Hu View author publications You can also


search for this author inPubMed Google Scholar * J Li View author publications You can also search for this author inPubMed Google Scholar * X Shi View author publications You can also


search for this author inPubMed Google Scholar * Y Hao View author publications You can also search for this author inPubMed Google Scholar * Y Li View author publications You can also


search for this author inPubMed Google Scholar * C Huang View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHORS Correspondence to L Song


or C Huang. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no conflict of interest. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Song,


L., Gao, M., Dong, W. _et al._ p85α mediates p53 K370 acetylation by p300 and regulates its promoter-specific transactivity in the cellular UVB response. _Oncogene_ 30, 1360–1371 (2011).


https://doi.org/10.1038/onc.2010.506 Download citation * Received: 03 April 2010 * Revised: 26 September 2010 * Accepted: 26 September 2010 * Published: 08 November 2010 * Issue Date: 17


March 2011 * DOI: https://doi.org/10.1038/onc.2010.506 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable


link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * acetylation * p85α * p53 * p300 * UVB


radiation